Sotagliflozin FDA:FDA Approves Sotagliflozin

FDA Approves Sotagliflozin

FDA Approves Sotagliflozin

2023年5月27日—TheFDAlateFridayapprovedsotagliflozin,thefirstdualsodium-glucosecotransporter1and2(SGLT1/2)inhibitor,forthetreatmentof ...。其他文章還包含有:「DualSGLT1andSGLT2inhibitorsotagliflozinachieves...」、「FDAApprovesSotagliflozinforTreatmentofHeartFailure」、「FDAUpdate」、「Inpefa(sotagliflozin)FDAApprovalHistory」、「Inpefa(sotagliflozin)tablets」、「INPEFATM(sotagliflozin)tablets」...

查看更多 離開網站

Provide From Google
Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves ...
Dual SGLT1 and SGLT2 inhibitor sotagliflozin achieves ...

https://www.nature.com

The FDA has approved sotagliflozin for the reduction of major heart-failure events in patients with and or diabetes, an indication that closely ...

Provide From Google
FDA Approves Sotagliflozin for Treatment of Heart Failure
FDA Approves Sotagliflozin for Treatment of Heart Failure

https://www.hcplive.com

The FDA approval of sotagliflozin (Inpefa) for the treatment of heart failure was announced by Lexicon Pharmaceuticals on May 26, 2023.

Provide From Google
FDA Update
FDA Update

https://www.acc.org

The once-daily oral tablet is approved to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits in adult ...

Provide From Google
Inpefa (sotagliflozin) FDA Approval History
Inpefa (sotagliflozin) FDA Approval History

https://www.drugs.com

Inpefa (sotagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of heart failure.

Provide From Google
Inpefa (sotagliflozin) tablets
Inpefa (sotagliflozin) tablets

https://www.accessdata.fda.gov

for Inpefa (sotagliflozin) tablets. This NDA provides for the use of ... Form FDA 2253 is available at FDA.gov.4. Information and Instructions ...

Provide From Google
INPEFATM (sotagliflozin) tablets
INPEFATM (sotagliflozin) tablets

https://www.accessdata.fda.gov

See 17 for PATIENT COUNSELING INFORMATION and. FDA-approved Medication Guide. Revised: 05/2023. FULL PRESCRIBING INFORMATION: CONTENTS*. 1 INDICATIONS AND USAGE.

Provide From Google
Sotagliflozin Gets FDA Approval in HF Across EF Spectrum
Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

https://www.tctmd.com

The US Food and Drug Administration has approved sotagliflozin for the prevention of cardiovascular death, hospitalization for heart failure (HF) ...

Provide From Google
禮來!FDA批准糖尿病藥SGLT12雙重抑制劑治療心衰竭
禮來!FDA批准糖尿病藥SGLT12雙重抑制劑治療心衰竭

https://news.gbimonthly.com

Sotagliflozin是首個用於治療第1型和第2型糖尿病的SGLT2與SGLT1雙重抑制劑。該藥是由Lexicon與賽諾菲(Sanofi)共同合作開發,但在2019年,由於多項臨床試驗 ...